scispace - formally typeset
J

Jerrold M. Olefsky

Researcher at University of California, San Diego

Publications -  606
Citations -  83310

Jerrold M. Olefsky is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 143, co-authored 595 publications receiving 77356 citations. Previous affiliations of Jerrold M. Olefsky include University of Colorado Boulder & University of Michigan.

Papers
More filters
Journal ArticleDOI

Fat Talks, Liver and Muscle Listen

TL;DR: Cao et al. (2008) take this concept a step further by identifying a fatty acid metabolite generated in adipose tissue that regulates insulin sensitivity in liver and muscle.
Journal ArticleDOI

Suppression of Egr‐1 transcription through targeting of the serum response factor by oncogenic H‐Ras

TL;DR: The findings suggest a novel signaling mechanism by which prolonged activation of oncogenic H‐Ras can trigger the loss of tumor suppressor Egr‐1 through the PI3K pathway in NIH3T3 fibroblast model cell lines.
Journal ArticleDOI

Insulin activates p21Ras and guanine nucleotide releasing factor in cells expressing wild type and mutant insulin receptors.

TL;DR: Results indicated that p 21Ras.GTP is an important signaling molecule in insulin's mitogenic pathway, but may not participate in metabolic signaling and that insulin's stimulatory effects on p21Ras are mediated through Ras GRF.
Journal ArticleDOI

Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).

TL;DR: The data suggest that the expression of PLSCR3 may be required for normal adipocyte and/or macrophage maturation or function and raise the possibility that deletions or mutations affecting the PL SCR3(-/-) gene locus may contribute to the risk for lipid-related disorders in humans.
Journal ArticleDOI

The effect of ten days of fasting on various aspects of carbohydrate metabolism in obese diabetic subjects with significant fasting hyperglycemia.

TL;DR: The beneficial effects of the 10-day period of caloric deprivation were transitory and fasting plasma glucose values had returned to prefast levels in most patients within a few months.